Abstract |
Although immunosuppressed patients may be more prone to SARS-CoV-2 infection with atypical presentation, long-term immunosuppression therapy may provide some sort of protection for severe clinical complications of COVID-19. The interaction between immunosuppression and new antiviral drugs in the treatment of transplanted patients contracting COVID-19 has not yet been fully investigated. Moreover, data regarding the optimal management of these patients are still very limited. We report a case of the successful recovery from severe COVID-19 of a kidney-transplanted patient treated with hydroxychloroquine, lopinavir/ ritonavir, steroid, and tocilizumab.
|
Authors | Andrea Lauterio, Mila Valsecchi, Sara Santambrogio, Riccardo De Carlis, Marco Merli, Angelo Calini, Leonardo Centonze, Vincenzo Buscemi, Maurizio Bottiroli, Massimo Puoti, Roberto Fumagalli, Luciano De Carlis |
Journal | Transplant infectious disease : an official journal of the Transplantation Society
(Transpl Infect Dis)
Vol. 22
Issue 5
Pg. e13334
(Oct 2020)
ISSN: 1399-3062 [Electronic] Denmark |
PMID | 32449235
(Publication Type: Case Reports, Journal Article)
|
Copyright | © 2020 Wiley Periodicals LLC. |
Chemical References |
- Antibodies, Monoclonal, Humanized
- Antiviral Agents
- Heparin, Low-Molecular-Weight
- Immunosuppressive Agents
- Lopinavir
- Hydroxychloroquine
- Prednisolone
- tocilizumab
- Ritonavir
|
Topics |
- Antibodies, Monoclonal, Humanized
(therapeutic use)
- Antiviral Agents
(therapeutic use)
- COVID-19
(diagnosis, immunology, therapy, virology)
- Drug Therapy, Combination
(methods)
- Female
- Graft Rejection
(immunology, prevention & control)
- Heparin, Low-Molecular-Weight
(therapeutic use)
- Humans
- Hydroxychloroquine
(therapeutic use)
- Immunosuppression Therapy
(adverse effects)
- Immunosuppressive Agents
(adverse effects)
- Kidney Transplantation
(adverse effects)
- Lopinavir
(therapeutic use)
- Lung
(diagnostic imaging)
- Middle Aged
- Prednisolone
(therapeutic use)
- Respiration, Artificial
- Ritonavir
(therapeutic use)
- SARS-CoV-2
(immunology, isolation & purification)
- Severity of Illness Index
- Tomography, X-Ray Computed
- Treatment Outcome
|